Secondary glaucoma in patients with juvenile rheumatoid arthritis-associated iridocyclitis
Authors: Foster, C.S.1; Havrlikova, K.1; Baltatzis, S.1; Christen, W.G.1; Merayo-Lloves, J.1
Source: Acta Ophthalmologica Scandinavica, Volume 78, Number 5, 1 October 2000 , pp. 576-579(4)
Publisher: Blackwell Publishing
Key:
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
Abstract:
.Purpose: The prevalence and management of glaucoma were evaluated in patients with juvenile rheumatoid arthritis (JRA)-associated iridocyclitis.Methods: The records of 69 patients with JRA-associated iridocyclitis were reviewed.Results: Twenty-nine (42%) of these patients had secondary glaucoma or ocular hypertension. Glaucoma was controlled with topical treatment in only 7 of the 41 affected eyes (17%); systemic carbonic anhydrase inhibitor therapy resulted in control of another 8 eyes. Surgery controlled all but one of the remainder.Conclusion: Glaucoma is a common complication of JRA-associated iridocyclitis. It results from prolonged, inadequately treated intraocular inflammation and in some instances, from steroid use. Medical and surgical therapy for the glaucoma associated with JRA-uveitis is challenging and incompletely effective. We suspect that a more aggressive approach to the treatment of JRA-associated uveitis, earlier in the course of the disease may reduce this vision robbing contribution to the process.Keywords: juvenile rheumatoid arthritis; uveitis; glaucoma; iritis and iridocyclitis
Document Type: Original article
Affiliations: 1: Massachusetts Eye & Ear Infirmary, Harvard Medical School, Department of Ophthalmology, Boston, Massachusetts, USA
Key:
- Free Content
- New Content
- Subscribed Content
- Free Trial Content

Click here for Page Help